Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials
- PMID: 3277662
- DOI: 10.1111/j.1471-0528.1988.tb06476.x
Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials
Abstract
Prophylactic use of oxytocics reduces the risk of postpartum haemorrhage by about 40%. The analysis presented in this paper assesses which oxytocic preparation is associated with the least risk of postpartum haemorrhage and examines the relative effects of different preparations on the length of the third stage, the risk of manual removal of the placenta, blood pressure and other side-effects. A mixture of oxytocin and ergometrine (Syntometrine) appears to be the safest and most effective prophylactic of the alternatives which have been compared, but the quality of the evidence is not satisfactory. There is scope for a randomized comparison of Syntometrine with oxytocin to obtain unbiased and more precise estimates of their relative effects on postpartum haemorrhage, blood pressure and unpleasant side-effects.
Similar articles
-
A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour.Hum Reprod. 2001 Jan;16(1):31-35. doi: 10.1093/humrep/16.1.31. Hum Reprod. 2001. PMID: 11139532 Clinical Trial.
-
A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour.BJOG. 2002 Feb;109(2):173-7. doi: 10.1111/j.1471-0528.2002.01204.x. BJOG. 2002. PMID: 11905429 Clinical Trial.
-
Abu Dhabi third stage trial: oxytocin versus Syntometrine in the active management of the third stage of labour.Eur J Obstet Gynecol Reprod Biol. 1995 Feb;58(2):147-51. doi: 10.1016/0028-2243(94)02004-3. Eur J Obstet Gynecol Reprod Biol. 1995. PMID: 7774741 Clinical Trial.
-
The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.Online J Curr Clin Trials. 1993 Aug 13;Doc No 83:[2305 words; 32 paragraphs]. Online J Curr Clin Trials. 1993. PMID: 8306013 Review.
-
The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials.Br J Obstet Gynaecol. 1988 Jan;95(1):3-16. doi: 10.1111/j.1471-0528.1988.tb06475.x. Br J Obstet Gynaecol. 1988. PMID: 3277663 Clinical Trial.
Cited by
-
Plasma oxytocin during third stage of labour: comparison of natural and active management.BMJ. 1988 Jul 16;297(6642):167-9. doi: 10.1136/bmj.297.6642.167. BMJ. 1988. PMID: 3261614 Free PMC article. Clinical Trial.
-
A risk-benefit assessment of oxytocics in obstetric practice.Drug Saf. 1999 Apr;20(4):323-45. doi: 10.2165/00002018-199920040-00003. Drug Saf. 1999. PMID: 10230581 Review.
-
The Bristol third stage trial: active versus physiological management of third stage of labour.BMJ. 1988 Nov 19;297(6659):1295-300. doi: 10.1136/bmj.297.6659.1295. BMJ. 1988. PMID: 3144366 Free PMC article. Clinical Trial.
-
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.Cochrane Database Syst Rev. 2019 Apr 29;4(4):CD001808. doi: 10.1002/14651858.CD001808.pub3. Cochrane Database Syst Rev. 2019. PMID: 31032882 Free PMC article.
-
The development of oxytocic drugs in the management of postpartum haemorrhage.Ulster Med J. 2004 May;Suppl(Suppl):2-6. Ulster Med J. 2004. PMID: 15239206 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical